Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

2.35
Delayed Data
As of Oct 20
 -0.02 / -0.84%
Today’s Change
1.93
Today|||52-Week Range
4.70
-25.94%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues0.000.000.000.00--
 
Operating ExpensesGross Income0.000.000.000.00--
General Expenses305.4K344.7K337.3K466.4K
 
 
 
 
 
Research And Development35.6K53.0K23.7K15.8K
 
 
 
 
 
Total Operating Expenses305.4K344.7K337.3K466.4K
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-305.4K-344.7K-337.3K-466.4K
 
 
 
 
 
Extraordinary Charge0.00-847.3K----
 
 
Other Expenses-1.0K-12.0K-688.1K-1.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-291.1K-1.2M-1.0M-1.5M
 
 
 
 
 
Net Income-291.1K-1.2M-1.0M-1.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.7M2.7M3.3M5.1M
 
 
 
 
 
Shares To Calculate EPS Diluted2.7M2.7M3.3M5.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.10---$0.31--
 
 
 
EPS Diluted-$0.10-$0.40-$0.31-$0.32